| Optimizing BCI-FIT: Brain Computer Interface - Functional Implementation Toolkit (NCT04468919) | Oregon Health and Science University | 2022-07-15 |
| A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (NCT05126758) | Capricor Inc. | 2022-06-22 |
| Schulze Muscular Dystrophy Ability Clinical Study (NCT05409079) | AbiliTech Medical Inc. | 2022-05-26 |
| Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders (NCT04009408) | University of Calgary | 2022-05-01 |
| COMMAND Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis (NCT05035823) | Synchron Medical, Inc. | 2022-04-27 |
| SWITCH II Early Feasibility Study: Implantable BCI to Control a Digital Device for People With Paralysis (NCT05041114) | Synchron Medical, Inc. | 2022-04-21 |
| Defining Endpoints in Becker Muscular Dystrophy (NCT05257473) | Virginia Commonwealth University | 2022-04-13 |
| Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders (NCT05200702) | Institut de Myologie, France | 2022-01-05 |
| Assessment of Safety and Acute Effects of a Lower-limb Powered Dermoskeleton in Patients With Neuromuscular Disorders (NCT05199246) | Institut de Myologie, France | 2021-12-01 |
| Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability (NCT05881122) | Brock University | 2021-11-01 |
| Spanish Natural History Study for LAMA2 Muscular Dystrophy (NCT06924125) | Hospital Universitari Vall d'Hebron Research Institute | 2021-07-27 |
| Cycle Exercise in Wheelchair Users With Muscular Dystrophy or Cerebral Palsy (NCT04677010) | Rigshospitalet, Denmark | 2021-06-01 |
| Bullying in Youth With Muscular Dystrophy and Congenital Myopathies (NCT04733976) | Holland Bloorview Kids Rehabilitation Hospital | 2021-01-22 |
| COVID-19 Pandemic and Parents of Disabled Children (NCT04525742) | Gaziosmanpasa Research and Education Hospital | 2020-07-05 |
| Ablelite Pediatric Device Clinical Study (NCT04308447) | AbiliTech Medical Inc. | 2020-07-01 |
| NuroSleeve Powered Brace & Stimulation System to Restore Arm Function (NCT04798378) | Thomas Jefferson University | 2020-04-16 |
| Limb-Girdle Muscular Dystrophy Type 2I in Norway (NCT03930628) | University Hospital of North Norway | 2020-01-06 |
| Biomarker Development in LGMD2i (NCT04202627) | ML Bio Solutions, Inc. | 2019-12-01 |
| Evaluation of a Textile Scapula Orthosis (NCT04154098) | Swiss Federal Institute of Technology | 2019-11-01 |
| Telerehabilitation in Proximal Muscle Weakness (NCT04392518) | Koç University | 2019-09-15 |
| Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) (NCT03981289) | Virginia Commonwealth University | 2019-06-14 |
| Transmembrane Electromyography (TM-EMG) for the Assessment of Neuromuscular Function in the Oropharynx (NCT03986671) | Powell Mansfield Inc. | 2019-04-30 |
| First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food Effect (NCT03627494) | GlaxoSmithKline | 2018-08-30 |
| Device for Breathing Frequency Monitoring in Muscular Dystrophy (NCT04313595) | IRCCS Eugenio Medea | 2018-07-29 |
| LARA: Use of JACO2 Controlled by Joystick or by Voice Control System, in Muscular Dystrophy (NCT04313049) | IRCCS Eugenio Medea | 2018-07-01 |
| Wearability, Saefty and Usability Assessment for the Upper Limb Exoskeleton BRIDGE/EMPATIA (NCT03951844) | Alessandra Pedrocchi | 2018-06-26 |
| Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography (NCT03490214) | University of Erlangen-Nürnberg Medical School | 2018-06-01 |
| Turkish Version of The Measure of Processes of Care (MPOC) (NCT03508583) | Hacettepe University | 2018-05-01 |
| A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy (NCT03406780) | Capricor Inc. | 2018-04-04 |
| Pro-inflammatory Cytokines in Facioscapulohumeral Muscular Dystrophy (CYTOKINE-FSH) (NCT04694456) | Centre Hospitalier Universitaire de Nice | 2018-01-30 |
| [BrainConnexion] - Neurodevice Phase I Trial (NCT03811301) | National Neuroscience Institute | 2017-11-21 |
| Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases (NCT06666816) | IRCCS Eugenio Medea | 2017-10-27 |
| The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities (NCT03851107) | McGill University | 2017-09-01 |
| Long-Term Outcomes of Ataluren in Duchenne Muscular Dystrophy (NCT03179631) | PTC Therapeutics | 2017-07-06 |
| User-centred Assistive System for Arm Functions in Neuromuscular Subjects (NCT03127241) | Politecnico di Milano | 2017-06-16 |
| Self-management Training for Parents With Chronic Muscular Dystrophia (NCT02641275) | University Children's Hospital, Zurich | 2017-01-01 |
| Prognostic Factors , Morbidity and Mortality in Patients With Neuromuscular Disorders Admitted in ICU (NCT02685215) | Centre d'Investigation Clinique et Technologique 805 | 2016-03-01 |
| Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular Dystrophies (NCT03317171) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2016-02-28 |
| European Home Mechanical Ventilation Registry (NCT02315339) | ResMed | 2014-08-01 |
| Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies (NCT02109692) | University Hospital, Montpellier | 2014-05-19 |
| An Extension Study of Ataluren (PTC124) in Participants With Nonsense Mutation Dystrophinopathy (NCT02090959) | PTC Therapeutics | 2014-03-20 |
| Pilot Study of Cardiac MR in Patients With Muscular Dystrophy (NCT02921321) | Children's National Research Institute | 2014-01-01 |
| Drisapersen Duchenne Muscular Dystrophy (DMD) Treatment Protocol (NCT01890798) | GlaxoSmithKline | 2014-01-01 |
| A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects (NCT01803412) | BioMarin Pharmaceutical | 2013-05-01 |
| Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD) (NCT01826487) | PTC Therapeutics | 2013-03-26 |
| Power Over Pain (POP) Study (NCT01800604) | University of Washington | 2013-02-01 |
| Genetic and Physical Study of Childhood Nerve and Muscle Disorders (NCT01568658) | National Institute of Neurological Disorders and Stroke (NINDS) | 2012-03-20 |
| Dysferlinopathy Protein in Peripheral Blood Monocytes. (NCT06507215) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2012-02-01 |
| A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD) (NCT01462292) | GlaxoSmithKline | 2011-10-26 |
| Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (NCT01480245) | GlaxoSmithKline | 2011-09-01 |
| A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (NCT01254019) | GlaxoSmithKline | 2010-12-02 |
| Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy (NCT01153932) | GlaxoSmithKline | 2010-09-01 |
| A Double-blind, Escalating Dose, Randomized, Placebo-controlled Study Assessing PK, Safety, Tolerability in Non-ambulant DMD Subjects (NCT01128855) | GlaxoSmithKline | 2010-07-12 |
| Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy - ACE Inhibitor Therapy Trial (NCT02432885) | InCor Heart Institute | 2009-06-01 |
| Safety Study of Transvenous Limb Perfusion in Human Muscular Dystrophy (NCT00873782) | University of North Carolina, Chapel Hill | 2009-03-01 |
| The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies (NCT00674843) | GAAD Medical Research Institute Inc. | 2008-05-01 |
| A Phase I/II, Open Label, Escalating Dose, Pilot Study to Assess Effect, Safety, Tolerability and PK of Multiple SC Doses of Drisapersen in Patients With Duchenne Muscular Dystrophy and to Assess the Potential for IV Dosing as an Alternative Route of Administration (NCT01910649) | BioMarin Pharmaceutical | 2008-03-01 |
| Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D) (NCT00494195) | Nationwide Children's Hospital | 2008-03-01 |
| Quality of Life in Neuromuscular Disease (NCT02895763) | CHU de Reims | 2006-06-01 |
| Muscle Tissue Bank for Muscular Dystrophy (NCT01950897) | Wake Forest University Health Sciences | 2005-08-24 |
| Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD) (NCT00027391) | FDA Office of Orphan Products Development | 2001-09-01 |
| Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 Skipping (NCT07250737) | Avidity Biosciences, Inc. | |